New Study Compares Caldolor® (ibuprofen injection) to ketorolac
Portfolio Pulse from
Cumberland Pharmaceuticals announced a study showing its Caldolor (ibuprofen injection) is safer and improves healthcare utilization compared to ketorolac, based on data from over 150,000 patients.
November 05, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cumberland Pharmaceuticals' study highlights the safety and healthcare benefits of Caldolor over ketorolac, potentially boosting its market position.
The study's findings that Caldolor is associated with fewer adverse reactions and improved healthcare utilization could enhance its market appeal, potentially leading to increased sales and a positive impact on CPIX stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100